Technology Platform: User-Friendly: Easy to navigate website/app Secure patient portal Clear instructions Works on mobile and desktop HIPAA-compliant security Issues: Confusing interface Frequent technical problems Poor mobile experience Security concerns No patient portal Questions to Ask Before Choosing: Essential Questions: Which providers will I see, and are they licensed in my state? What pharmacy will fill my prescription, and are they FDA-registered? Whats included in the monthly price? How often are follow-up appointments, and are they included? Can I choose between semaglutide and tirzepatide? What happens if I experience side effects? How do refills work? Whats your cancellation policy? Do you accept HSA/FSA? How quickly can I get started? If provider cant answer these clearly, thats a red flag
Early-phase clinical trials including a Phase 2 dose-ranging study published in the New England Journal of Medicine (2023) have demonstrated significant potential for weight reduction and metabolic improvement, generating considerable scientific interest
Lindsey SC, Ganly I, Palmer F, Tuttle RM
Effect of s-allylcysteine on oxidant-antioxidant status during n-Methyl-N-Nitro-N-Nitrosoguanidine and saturated sodium chloride-induced gastric carcinogenesis in wistar rats
Kenneth McCall suggests that compounded GLP-1s pose may more safety issues than their manufactured counterparts
It remains an investigational drug undergoing clinical trials, and there is no legitimate supply route outside of authorised research settings
